Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis ( PPF)

被引：0
|
作者：
Wuyts, Wim A. [1 ]
Maher, Toby M. [2 ]
Wijsenbeek, Marlies [3 ]
Koschel, Dirk [4 ]
Martinez, Fernando J. [5 ]
Stansen, Wibke [6 ]
Stowasser, Susanne [7 ]
Richeldi, Luca [8 ]
机构：
[1] Univ Hosp Leuven, Dept Pulm Med, Unit Interstitial Lung Dis, Leuven, Belgium
[2] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[3] Univ Med Ctr, Dept Resp Med, Erasmus MC, Rotterdam, Netherlands
[4] Fachkrankenhaus Coswig, Coswig, Germany
[5] Weill Cornell Med, New York, NY USA
[6] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[7] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[8] Univ Cattolica Sacro Cuore, Fdn Policlin Gemelli IRCCS, Rome, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2875
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF)
    Koschel, D.
    Wuyts, W.
    Maher, T.
    Wijsenbeek, M.
    Martinez, F.
    Stansen, W.
    Stowasser, S.
    Richeldi, L.
    PNEUMOLOGIE, 2024, 78 : S81 - S82
  • [2] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    James Patrick Finnerty
    Aravind Ponnuswamy
    Prosjenjit Dutta
    Ammar Abdelaziz
    Hafiz Kamil
    BMC Pulmonary Medicine, 21
  • [3] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    Finnerty, James Patrick
    Ponnuswamy, Aravind
    Dutta, Prosjenjit
    Abdelaziz, Ammar
    Kamil, Hafiz
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [4] Decline in forced vital capacity (FVC) in subjects with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) compared with healthy references
    Valenzuela, Claudia
    Bonella, Francesco
    Moor, Catharina C.
    Weimann, Gerrit
    Miede, Corinna
    Stowasser, Susanne
    Maher, Toby M.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [5] Predicting Mortality in Idiopathic Pulmonary Fibrosis (IPF) Patients Treated with Nintedanib
    Tang, W.
    Menjoge, S.
    Stowasser, S.
    Korell, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Nintedanib in Progressive Pulmonary Fibrosis A Systematic Review and Meta-Analysis
    Ghazipura, Marya
    Mammen, Manoj J.
    Herman, Derrick D.
    Hon, Stephanie M.
    Bissell, Brittany D.
    Macrea, Madalina
    Kheir, Fayez
    Khor, Yet H.
    Knight, Shandra L.
    Raghu, Ganesh
    Wilson, Kevin C.
    Hossain, Tanzib
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (06) : 1040 - 1049
  • [7] Nebulised pirfenidone in non-idiopathic pulmonary fibrosis (IPF) progressive pulmonary fibrosis (PPF): first look at FVC data
    West, Alex
    Lawrence, Alexandra
    Bao, Hao
    Nair, Deepthi
    Thompson, Courtney
    Woodhead, Felix
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] Nintedanib in progressive Non-IPF-Pulmonary Fibrosis - A Subgroup Analysis
    Markart, Philipp
    PNEUMOLOGE, 2020, 17 (05): : 350 - 351
  • [9] Progressive pulmonary fibrosis (PPF)
    Duman, Dildar
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2022, 70 (04): : 375 - 381
  • [10] Colitis Associated with Nintedanib Therapy for Idiopathic Pulmonary Fibrosis (IPF)
    Oda, Keishi
    Matsunaga, Takafumi
    Sennari, Konomi
    Yatera, Kazuhiro
    INTERNAL MEDICINE, 2017, 56 (10) : 1267 - 1268
12345